To reverse intrinsic immune suppression in HL, post-CD30-CAR T PD-1 blockade has been studied in multiple studies showing improved expansion of CD30-CAR T and duration of response (152, 159, 160). Here, TNFRSF8 is linked to Hodgkins lymphoma.